[면역학] 에볼라 바이러스 분석 레포트(영문)

소개

"[면역학] 에볼라 바이러스 분석 레포트(영문)"에 대한 내용입니다.

목차

1. The Characterization of virus
2. The life cycle of pathogen
3. Pathogenesis and symptom
4. Host protective immune responses
5. Immune Evasion of Virus
6. The current problem of the disease.
7. Suggest specific solution

본문내용

Ebola virus disease(EVD) is the epidemic disease caused by the Ebola virus. EVD is associated with severe and fatal hemorrhagic fever which is flu-like fever with symptoms of internal bleeding that usually result in the death of the infected people.

The Characterization of virus
Ebola viruses belong to the genus Ebolavirus, and the family Filoviridae, and the order Mononegavirales. There are five species in the genus Ebolavirus. Each of these are Bunibugyo ebolavirus(Bundibugyo virus), Reston ebolavirus(Reston virus), Sudan ebolavirus(Sudan virus), Tai Forest ebolavirus(Bai Forest virus), and Zaire ebolavirus(Ebola virus). Among these, only Bundibungyo, Sudan, and Ebola viruses are the only viruses that can infect human beings. These viruses had caused over 20 outbreaks between 1976 and 2014. The fatalities of viruses are various, but the Ebola virus disease’s fatality has been 80%. The largest outbreak occurred in West Africa from..

<중 략>

참고자료

· Denis Malvy, et al., Ebola virus disease, Lancet,393:936-48, 2019
· Shevin T. Jacob, et al., Ebola virus disease, Nat. Rev., 6:13, 2020
· Sahil Jain, et al., Structural and Functional Aspects of Ebola Virus Proteins, pathogens, 10, 1330, 2021
· Thomas Hoenen, Allison Groseth, and Heinz Feldmann, Therapeutic strategies to target the Ebola virus life cycle, Nat. Rev., 17:593-606, 2019
· Wenjun Zhu, et al., the roles of Ebola Virus Soluble Glycoprotein in Replication, Pathogenesis, and Counter measure Development, Viruses, 11,999,2019
· Nancy Sullivan, et al., Ebola Virus Pathogenesis: Implications for Vaccines and Therapies, J. Virol., 77”9733-9737, 2003
· L. Falasca, et al., Molecular mechanisms of Ebola virus pathogenesis: focus on cell death, Cell Death Differ., 22:1250-1259, 2015
· Gary Wong, Gary P. Kobinger, and Xiangguo Qiu. Characterization of host immune responses in Ebola virus infections, Rev. Clin. Immunol., 10(6), 781-790, 2014
· Baize S, Leroy EM, Georges AJ, et al. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol, 128(1):163-8, 2002
· Mohamadzadeh, et al., Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by Marburg and ebola viruses, J. Virol. 80: 7235-724, 2006
· Aurelie Ploquin, Yan Zhou, and Nancy J. Sullivan, Ebola Immunity: Gaining a Winning Position in Lightning Chess, J. Immunol.,201:833-842, 2018
· Ruibal P., et al., Unique human immune signature of Ebola virus disease in Guinea. Nature 533:100-104, 2016
· Basler, C. F. Innate immune evasion by filoviruses, Virology 479-480:122-130, 2015
· Geisbert T. W., et al., Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are earl and sustained targets of infection, Am J. Pathol. 163:2347-2370
· Misasi J., and N. J. Sullivan, Camouflage and misdirection: the full-on assault of ebola virus disease. Cell 159:477-486, 2014
· Messaoudi I., G. K. Amarasinghe, and C. F. Basler, Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus, Nat. Rev. Microbiol. 13:663-676